Impact of the 2018 ASCO/CAP guidelines on HER2 fluorescence in situ hybridization interpretation in invasive breast cancers with immunohistochemically equivocal results
Crossref DOI link: https://doi.org/10.1038/s41598-019-53003-w
Published Online: 2019-11-13
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Bo
Ding, Wei
Sun, Ke
Wang, Xiaoling
Xu, Liming
Teng, Xiaodong
Text and Data Mining valid from 2019-11-13
Version of Record valid from 2019-11-13
Article History
Received: 22 August 2019
Accepted: 25 October 2019
First Online: 13 November 2019
Competing interests
: The authors declare no competing interests.